Journal article
2026-02-01T00:00:00+00:00
24
342 - 345
3
biotechnology innovation, de-risking, human factors research, human-technology interaction, minimum desirable product (MDP), minimum viable product (MVP), product–market fit, psychometric scale development, risk assessment and derisking, technology adoption, transcutaneous vaccine delivery, vaccine hesitancy